GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cangene Corporation (FRA:YGE) » Definitions » Gross Margin %

Cangene (FRA:YGE) Gross Margin % : 36.67% (As of Oct. 2013)


View and export this data going back to . Start your Free Trial

What is Cangene Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Cangene's Gross Profit for the three months ended in Oct. 2013 was €6.62 Mil. Cangene's Revenue for the three months ended in Oct. 2013 was €18.04 Mil. Therefore, Cangene's Gross Margin % for the quarter that ended in Oct. 2013 was 36.67%.


The historical rank and industry rank for Cangene's Gross Margin % or its related term are showing as below:


FRA:YGE's Gross Margin % is not ranked *
in the Biotechnology industry.
Industry Median: 59.33
* Ranked among companies with meaningful Gross Margin % only.

Cangene had a gross margin of 36.67% for the quarter that ended in Oct. 2013 => Competition eroding margins

The 5-Year average Growth Rate of Gross Margin for Cangene was 0.00% per year.


Cangene Gross Margin % Historical Data

The historical data trend for Cangene's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cangene Gross Margin % Chart

Cangene Annual Data
Trend Jul04 Jul05 Jul06 Jul07 Jul08 Jul09 Jul10 Jul11 Jul12 Jul13
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 50.23 37.07 35.87 23.11 41.07

Cangene Quarterly Data
Jan09 Apr09 Jul09 Oct09 Jan10 Apr10 Jul10 Oct10 Jan11 Apr11 Jul11 Oct11 Jan12 Apr12 Jul12 Oct12 Jan13 Apr13 Jul13 Oct13
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 38.79 30.86 54.94 33.11 36.67

Competitive Comparison of Cangene's Gross Margin %

For the Biotechnology subindustry, Cangene's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cangene's Gross Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cangene's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Cangene's Gross Margin % falls into.



Cangene Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Cangene's Gross Margin for the fiscal year that ended in Jul. 2013 is calculated as

Gross Margin % (A: Jul. 2013 )=Gross Profit (A: Jul. 2013 ) / Revenue (A: Jul. 2013 )
=39.9 / 97.269
=(Revenue - Cost of Goods Sold) / Revenue
=(97.269 - 57.322) / 97.269
=41.07 %

Cangene's Gross Margin for the quarter that ended in Oct. 2013 is calculated as


Gross Margin % (Q: Oct. 2013 )=Gross Profit (Q: Oct. 2013 ) / Revenue (Q: Oct. 2013 )
=6.6 / 18.043
=(Revenue - Cost of Goods Sold) / Revenue
=(18.043 - 11.427) / 18.043
=36.67 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Cangene  (FRA:YGE) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Cangene had a gross margin of 36.67% for the quarter that ended in Oct. 2013 => Competition eroding margins


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Cangene Gross Margin % Related Terms

Thank you for viewing the detailed overview of Cangene's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Cangene (FRA:YGE) Business Description

Traded in Other Exchanges
N/A
Address
Cangene Corporation is a fully integrated developer and manufacturer of immune therapeutics, primarily targeting infectious disease, hematology, transplantation and biodefense applications. The company manages its business and evaluate performance based on two operating segments: biopharmaceutical operations and contract services. Revenues are generated from product sales, and contract manufacturing and contract-R&D services.

Cangene (FRA:YGE) Headlines

No Headlines